ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      19,252.80
      2.10%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      73.775
      1.93%
      Bitcoin
      62,407.97
      1.19%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Akcea Therapeutics Inc (AKCA) Quote

      Akcea Therapeutics Inc

      Akcea Therapeutics Inc (AKCA)

      NASDAQ
      18.17
      0.00
      (0.00%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      18.17
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      18.17
      Bid
      18.08
      Ask
      19.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      18.17
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      AKCA Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      21 hours ago

      Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

      Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif., Oct...

      October 30 2020
      PR Newswire (US)

      Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

      Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more efficient company PR Newswire CARLSBAD, Calif., Oct. 12, 2020 CARLSBAD, Calif., Oct. 12...

      October 12 2020
      PR Newswire (US)

      WAYLIVRA▼® (volanesorsen), the First & Only Therapy for FCS, an Ultra-Rare & Life-Threatening Condition, to Be Available o...

      National Institute for Health and Care Excellence (NICE) issues a positive recommendation for volanesorsen to treat adults with Familial Chylomicronaemia Syndrome (FCS) Akcea Therapeutics UK...

      September 18 2020
      Business Wire

      Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics

      Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics - Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash - Transaction...

      August 31 2020
      PR Newswire (US)

      Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020

      Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 Results from Phase 2 study demonstrate patients receiving vupanorsen experienced significant...

      August 29 2020
      PR Newswire (US)

      Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020

      Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 Results in late-breaking presentation show patients with hypertriglyceridemia experienced dose-dependent...

      August 29 2020
      PR Newswire (US)

      Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020

      Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020 Late-breaking presentation to focus on efficacy and safety data of vupanorsen in...

      August 24 2020
      PR Newswire (US)

      Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020

      Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020 Data presentation will highlight efficacy, safety and tolerability of...

      August 18 2020
      PR Newswire (US)

      Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany

      Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany WAYLIVRA is the only treatment option for patients with familial chylomicronemia syndrome, or FCS, in...

      August 13 2020
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ZEOZeo Energy Corporation
      $ 3.96
      (247.37%)
      		3.8M
      TBIOTelesis Bio Inc
      $ 3.98
      (192.65%)
      		6.57M
      XCURExicure Inc
      $ 6.47
      (182.53%)
      		3.46M
      VEROVenus Concept Inc
      $ 0.8334
      (65.85%)
      		3.3M
      FRGTFreight Technologies Inc
      $ 0.1721
      (38.90%)
      		26M
      PGNYProgyny Inc
      $ 17.62
      (-27.91%)
      		70.77k
      SBCSBC Medical Group Holdings Incorporated
       6.00
      (-21.67%)
      		25.47k
      ATMCAlphaTime Acquisition Corporation
      $ 9.00
      (-19.64%)
      		10
      CUTRCutera Inc
      $ 0.64
      (-16.05%)
      		13
      WBUYWeBuy Global Ltd
      $ 0.1558
      (-15.46%)
      		580.26k
      FRGTFreight Technologies Inc
      $ 0.1721
      (38.90%)
      		26M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.0976
      (7.37%)
      		14.14M
      TBIOTelesis Bio Inc
      $ 3.98
      (192.65%)
      		6.57M
      VMARVision Marine Technologies Inc
      $ 0.7299
      (21.04%)
      		4.77M
      ZEOZeo Energy Corporation
      $ 3.96
      (247.37%)
      		3.8M

      AKCA Discussion

      View Posts
      Sidney Sidney 6 years ago
      Any thoughts on why so low today?
      👍️0
      Thoro Thoro 7 years ago
      So Volatile. Any thoughts on why the big plunge today?
      👍️0
      Rodney213 Rodney213 7 years ago
      Like how clean the board is .Some heavy price target coverage today
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      Dropped heavy yesterday but bounced back some today. I am still up 17%, so I am not complaining.
      👍️0
      Thoro Thoro 7 years ago
      This is a volatile stock. Its finding its legs.
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      Closed at $15.43 today up 47 cents.
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      Back up $1.02 today. This stock is like riding a roller coaster. Up one day and down the next. And big drops and rises too.
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      WTH happened today? Down $1.52!
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      Closed up 40 cents at $14.88
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      It was up big earlier but steadily dropping now. Still up 14 cents at 2:45 EST
      👍️0
      Thoro Thoro 7 years ago
      AKCA, Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency

      https://ih.advfn.com/p.php?pid=nmona&article=75321782
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      Closed up at $14.48 (5.16%). Nice!
      👍️0
      Thoro Thoro 7 years ago
      I know it dropped, but I like when it tests higher.
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      Yes, but it dropped to $13.77. I still believe in it though.
      👍️0
      Thoro Thoro 7 years ago
      AKCA $16.30 looked great today!
      👍️0
      dinosaurbob dinosaurbob 7 years ago
      I bought in at 9.88 and then doubled my portfolio Friday at $13.00. I see this over $20.00 by October!
      👍️0
      Thoro Thoro 7 years ago
      AKCA

      IPO doing great first 5 days of trading.
      👍️0
      Thoro Thoro 7 years ago
      AKCA

      #MARKET NEWS
      JULY 14, 2017 / 12:12 PM / 3 DAYS AGO
      BRIEF-Akcea Therapeutics Inc shares open at $8.13 in debut vs IPO price of $8/share

      http://www.reuters.com/article/brief-akcea-therapeutics-inc-shares-open-idUSFWN1K50CZ




      👍️0
      Thoro Thoro 7 years ago
      AKCA

      #MARKET NEWS
      JULY 13, 2017 / 8:30 PM / 4 DAYS AGO

      BRIEF-Akcea Therapeutics says public offering of 15.6 mln common shares priced at $8 per share

      http://www.reuters.com/article/brief-akcea-therapeutics-says-public-off-idUSASA09X2O

      👍️0

      Your Recent History

      NASDAQ
      AKCA
      Akcea Therapeutics
      Delayed Upgrade Clock